A S4125,1716-12-7 CEP of the European Pharmacopoeia monograph is often referred to as a S4125,1716-12-7 Certificate of Suitability (COS). The purpose of a S4125,1716-12-7 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of S4125,1716-12-7 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of S4125,1716-12-7 to their clients by showing that a S4125,1716-12-7 CEP has been issued for it. The manufacturer submits a S4125,1716-12-7 CEP (COS) as part of the market authorization procedure, and it takes on the role of a S4125,1716-12-7 CEP holder for the record. Additionally, the data presented in the S4125,1716-12-7 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the S4125,1716-12-7 DMF.
A S4125,1716-12-7 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. S4125,1716-12-7 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of S4125,1716-12-7 suppliers with CEP (COS) on PharmaCompass.